Christopher Frankenfield

Christopher Frankenfield

Chief Operating Officer at XILIO THERAPEUTICS, INC.

Net worth: - $ as of 30/03/2024

42 year
Health Technology
Consumer Services
Commercial Services

Profile

Christopher Frankenfield is currently the Chief Operating Officer at Xilio Therapeutics, Inc. He previously worked as a Senior Associate at Wilmer Cutler Pickering Hale & Dorr LLP and as a Vice President-Corporate & Legal Affairs at Blueprint Medicines Corp.
He completed his undergraduate degree at The College of William & Mary and his graduate degree at the University of Virginia School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2023 0 ( -.--% ) - $ 30/03/2024

Christopher Frankenfield active positions

CompaniesPositionStart
XILIO THERAPEUTICS, INC. Chief Operating Officer 02/08/2023
All active positions of Christopher Frankenfield

Former positions of Christopher Frankenfield

CompaniesPositionEnd
Corporate Officer/Principal -
BLUEPRINT MEDICINES CORPORATION General Counsel -
See the detail of Christopher Frankenfield's experience

Training of Christopher Frankenfield

The College of William & Mary Undergraduate Degree
University of Virginia School of Law Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Frankenfield's experience

Connections

28

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BLUEPRINT MEDICINES CORPORATION

Health Technology

XILIO THERAPEUTICS, INC.

Health Technology

Private companies1

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Frankenfield